A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

The SeattleStatGROWS program (Statistical Growing Research Opportunities for Undergraduates in Washington State) is a Fred ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

ASH will recognize Rainer Storb, MD, with the Wallace H. Coulter Award for Lifetime Achievement in Hematology, the society's highest honor. See below for summaries and links to selected Fred Hutch ...

In this episode of Oncology Insights, Dr. Petros Grivas and Dr. Rachael Safyan discuss the advancements in gastrointestinal ...

Faculty profile for Dr. Steven Blinka. Dr. Blinka is a board-certified medical oncologist whose research focuses on understanding the genetic drivers of disease, response and treatment resistance in ...

After surgery for prostate cancer, Todd Elworthy’s PSA came back elevated. Radiation was advised as the next step and Elworthy looked into a Fred Hutch clinical trial and proton therapy. Though he ...